Success rates for product development strategies in new drug development

Keywords

clinical trials, product development

Abstract

While research has examined the likelihood that drugs progress across phases of clinical trials, no research to date has examined the types of product development strategies that are the most likely to be successful in clinical trials. This research seeks to identify the strategies that are most likely to reach the market—those generated using a novel product development strategy or strategies that combine a company's expertise with both drugs and indications, which we call combined experience strategies.

Original Publication Citation

Dahlin, Eric, Greg Nelson, Meagan Haynes,† and Francis Sargeant.† 2016. “Success Rates for Product Development Strategies in New Drug Development.” Journal of Clinical Pharmacy & Therapeutics 41:198-202

Document Type

Peer-Reviewed Article

Publication Date

2016-02-15

Permanent URL

http://hdl.lib.byu.edu/1877/5419

Publisher

Journal of Clinical Pharmacy and Therapeutics

Language

English

College

Family, Home, and Social Sciences

Department

Sociology

University Standing at Time of Publication

Full Professor

Link to Full Text

Share

COinS